[HTML][HTML] Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity
M Sterba, P Pokorna, R Faberova, B Pinkova… - Scientific reports, 2023 - nature.com
This was a prospective cohort study of eighteen patients with large and debilitating vascular
malformations with one or more major systemic complications. In all patients, we discovered …
malformations with one or more major systemic complications. In all patients, we discovered …
[PDF][PDF] Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity
M Sterba, P Pokorna, R Faberova, B Pinkova… - Scientific Reports, 2023 - is.muni.cz
Results In each patient, activating mutations in either TEK or PIK3CA were found. In 12/18
patients, TEK exon 17 mutation was found, with TEK p. L914F being the most prevalent …
patients, TEK exon 17 mutation was found, with TEK p. L914F being the most prevalent …
Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity
M Sterba, P Pokorna, R Faberova… - Scientific …, 2023 - pubmed.ncbi.nlm.nih.gov
This was a prospective cohort study of eighteen patients with large and debilitating vascular
malformations with one or more major systemic complications. In all patients, we discovered …
malformations with one or more major systemic complications. In all patients, we discovered …
Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly efective with limited toxicity
M Štěrba, P Pokorná, R Faberová, B Pinková… - 2023 - med.muni.cz
This was a prospective cohort study of eighteen patients with large and debilitating vascular
malformations with one or more major systemic complications. In all patients, we discovered …
malformations with one or more major systemic complications. In all patients, we discovered …
Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity.
M Sterba, P Pokorna, R Faberova, B Pinkova… - Scientific …, 2023 - europepmc.org
This was a prospective cohort study of eighteen patients with large and debilitating vascular
malformations with one or more major systemic complications. In all patients, we discovered …
malformations with one or more major systemic complications. In all patients, we discovered …
Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity
M Štěrba, P Pokorná, R Faberová, B Pinková… - Scientific Reports, 2023 - repozitar.cz
This was a prospective cohort study of eighteen patients with large and debilitating vascular
malformations with one or more major systemic complications. In all patients, we discovered …
malformations with one or more major systemic complications. In all patients, we discovered …
[HTML][HTML] Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity
M Sterba, P Pokorna, R Faberova, B Pinkova… - Scientific …, 2023 - ncbi.nlm.nih.gov
This was a prospective cohort study of eighteen patients with large and debilitating vascular
malformations with one or more major systemic complications. In all patients, we discovered …
malformations with one or more major systemic complications. In all patients, we discovered …
Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity.
M Sterba, P Pokorna, R Faberova… - Scientific …, 2023 - search.ebscohost.com
This was a prospective cohort study of eighteen patients with large and debilitating vascular
malformations with one or more major systemic complications. In all patients, we discovered …
malformations with one or more major systemic complications. In all patients, we discovered …
Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity
M Sterba, P Pokorna, R Faberova… - Scientific …, 2023 - ui.adsabs.harvard.edu
This was a prospective cohort study of eighteen patients with large and debilitating vascular
malformations with one or more major systemic complications. In all patients, we discovered …
malformations with one or more major systemic complications. In all patients, we discovered …
[PDF][PDF] Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity
M Sterba, P Pokorna, R Faberova, B Pinkova… - Scientific …, 2023 - avminority.cz
Results In each patient, activating mutations in either TEK or PIK3CA were found. In 12/18
patients, TEK exon 17 mutation was found, with TEK p. L914F being the most prevalent …
patients, TEK exon 17 mutation was found, with TEK p. L914F being the most prevalent …